ExodusPoint Capital Management’s Acceleron Pharma XLRN Stock Holding History

ExodusPoint Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,318	Closed	-$227K	–	2808
2021 Q3	$227K	Sell	1,318 -2,647	-67%	-$346K	﹤0.01%	1738
2021 Q2	$498K	Buy	+3,965	New	+$500K	0.01%	1438
2020 Q3	–	Sell	-31,242	Closed	-$2.98M	–	2401
2020 Q2	$2.98M	Buy	+31,242	New	+$3.01M	0.08%	293

ExodusPoint Capital Management's XLRN Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,318 shares — an estimated $227K sold.

ExodusPoint Capital Management first reported a position in XLRN in Q2 2020 and held it in 3 quarters. The position peaked at $2.98M in Q2 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

ExodusPoint Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 1,318 Acceleron Pharma shares in Q4 2021, an estimated $227K.
ExodusPoint Capital Management first reported a position in Acceleron Pharma in Q2 2020 and held it in 3 quarters.
ExodusPoint Capital Management's Acceleron Pharma position peaked at $2.98M in Q2 2020.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.